Effect of C-reactive Protein Point-of-care Testing on Antibiotic Prescribing for Acute Respiratory-tract Infections At Primary Care Facilities in Rural China
- Conditions
- Antibiotic Prescribing for Acute Respiratory-tract Infections
- Registration Number
- NCT06568432
- Lead Sponsor
- Huazhong University of Science and Technology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not yet recruiting
- Sex
- All
- Target Recruitment
- 19424
Inclusion Criteria:<br><br>Village clinics with an annual outpatient volume of more than 3000, with =10 patients per<br>week for acute respiratory infections, and with licensed prescribers were considered<br>eligible for selection for intervention.<br><br>Exclusion Criteria:<br><br>The target population of this study included (1) aged between 1 and 75 years old; (2)<br>Present with =1 acute respiratory symptoms (including cough, rhinitis (sneezing, nasal<br>congestion or runny nose), sore throat, shortness of breath, wheezing or abnormal<br>auscultation); (3) Diagnosed by a doctor as acute respiratory infection. Patients with<br>non-respiratory diseases or those with severe clinical symptoms requiring referral to a<br>higher level institution are excluded from the target population.
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Antibiotic prescription rates for all ARI patients in the intervention and control groups
- Secondary Outcome Measures
Name Time Method Proportion of patients in the intervention group and control group who were prescribed antibiotics due to ARI at first visit during the same period one year before the intervention began;Average cost of ARI prescriptions in the intervention and control groups;Proportion of newly diagnosed ARI patients prescribed antibiotics stratified by age, sex, symptoms , type of infection, and season.;Rate of multiple antibiotic prescriptions in intervention and control groups;Proportion of ARI patients in the intervention and control groups receiving follow-up antibiotics within 14 days of their first visit;Proportion of ARI patients in the intervention and control groups who visited the office again;Proportion of patients in the intervention and control groups admitted to a superior hospital within 14 days of their initial visit for ARI